Patents

Ambroxol To Improve Skin Barrier Function

Used topically to treat psoriasis or atopic dermatitis.

US Patent 11,730,690 B2 (Stephen Anderson) NeueRe, LLC, Princeton, NJ, has patented a method for treating psoriasis or atopic dermatitis by topically administering a composition comprising a low dose formulation of ambroxol (less than 0.1%).

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters